Tag Archives: ARQL

Best Biotech Stocks To Watch Right Now

What happened

For the second day in a row, biotech stock Berkeley Lights (NASDAQ:BLI) suffered a big investor sell-off, falling by almost 12% on Thursday. Even though an analyst tracking the stock issued a bullish new research note on the company, it continued to experience the fallout from a sharply worded tweet storm delivered by a short seller.

So what

Scorpion Capital’s six-tweet thread was published early on Wednesday, and it accused Berkeley Lights of “fleecing” both its customers and investors of its recent IPO.

The short seller said that....More>>>

Top 5 Biotech Stocks To Own Right Now

Since biotechnology company Cassava Sciences (NASDAQ:SAVA) is working hard to fight Alzheimer’s disease, it might be surprising to know that the company has some harsh critics. There’s a lot of drama going on with Cassava, and SAVA stock traders need to be aware of the latest developments.

Source: Atthapon Raksthaput / Shutterstock.com

Just to give you a primer, Cassava Sciences is developing an Alzheimer’s disease drug called simufilam. This drug is is Phase 3 ready in 2021, according to the company.

Top 5 Biotech Stocks To Own Right Now: Alnylam....More>>>

Hot Biotech Stocks To Buy Right Now

Zacks Investment Research upgraded shares of CYBIN INC. (CYBN.NE) (OTCMKTS:CYBN) from a hold rating to a buy rating in a report issued on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $2.25 target price on the stock.

According to Zacks, “Cybin Inc. is a biotechnology company. It is focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin Inc. is based in Toronto, Canada. “

....More>>>

Top Biotech Stocks To Watch Right Now

Amyris  (AMRS) – Get Report shares soared Friday after the biotech company announced promising in vivo results for a study of its licensed RNA vaccine for COVID through intranasal delivery.

The vaccine is being developed in collaboration with the Infectious Disease Research Institute, Amyris said.

Amyris recently traded at $13.67, up 13%.

“Current mRNA vaccine technologies are providing limited immunity protection for the upper respiratory system,” Amyris said. “As a result, vaccinated people may experience viral replication....More>>>

Hot Biotech Stocks To Own Right Now

Shares of Intercept Pharmaceuticals  (ICPT) – Get Report slipped Friday after Goldman Sachs downgraded the biotech firm to sell from neutral and lowered its price target to $10 from $17.

Shares of the New York company at last check fell 6.8% to $12.90.

Goldman analyst Salveen Richter, in a note published Friday, cited “ongoing uncertainty and lack of near-term, value-driving catalysts” as the reasons behind the downgrade, according to a Bloomberg report.

The regulatory path for Ocaliva as a treatment for fatty liver....More>>>